Noninvasive prediction of prostatic DNA damage by oxidative stress challenge of peripheral blood lymphocytes

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 9, 2007, Pages 1906-1910

  Waters, David J ^a,c,g   Shen, Shuren ^a,c   Xu, Huiping ^b   Kengeri, Seema S ^c   Cooley, Dawn M ^a   Chiang, Emily C ^a   Chen, Yu ^a   Schlittler, Deborah ^a,c   Oteham, Carol ^a   Combs Jr , Gerald F ^d   Glickman, Lawrence T ^a   Morris, J Steven ^e   Bostwick, David G ^f  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c Gerald P Murphy Cancer Foundation   (United States)

^d GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

^e UNIVERSITY OF MISSOURI   (United States)

^f BOSTWICK LABORATORIES   (United States)

^g Gerald P Murphy Cancer Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; SELENIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RISK; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DOG; IN VIVO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROSTATE CANCER; TESTOSTERONE BLOOD LEVEL;

ANIMALS; DNA DAMAGE; DOGS; HUMANS; LYMPHOCYTES; MALE; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 34548853391     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0034     Document Type: Article

References (43)

1. Lippman SM, Goodman PJ, Klein EA, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst 2005;97:94-102.
2. Cornell KK, Bostwick DG, Cooley DM, et al. Clinical and pathologic aspects of spontaneous canine prostate carcinoma: a retrospective analysis of 76 cases. Prostate 2000;45:173-83.
3. Waters DJ, Sakr WA, Hayden DW, et al. Workgroup 4: spontaneous prostate carcinoma in dogs and nonhuman primates. Prostate 1998;36:64-7.
4. Waters DJ, Patronek GJ, Bostwick DG, Glickman LT. Comparing the age at prostate cancer diagnosis in humans and dogs. J Natl Cancer Inst 1996;88:1686-7.
5. Waters DJ, Shen S, Cooley DM, et al. Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. J Natl Cancer Inst 2003;95:237-41.
6. Waters DJ, Shen S, Glickman LT, et al. Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model. Carcinogenesis 2005;26:1256-62.
7. Malins DC, Johnson PM, Wheeler TM, Barker EA, Polissar NL, Vinson MA. Age-related radical-induced DNA damage is linked to prostate cancer. Cancer Res 2001;61:6025-8.
8. Ripple MO, Henry WF, Rago RP, Wilding G. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J Natl Cancer Inst 1997;89:40-8.
9. Nelson WG, De Marzo AM, DeWeese TL. The molecular pathogenesis of prostate cancer: implications for prostate cancer prevention. Urology 2001;57:39-45.
10. Lockett KL, Hall MC, Clark PE, et al. DNA damage levels in prostate cancer cases and controls. Carcinogenesis 2006;27:1187-93.
11. Yoshizawa K, Willett WC, Morris JS, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998;90:1219-24.
12. Shen S, Cooley DM, Glickman LT, Glickman N, Waters DJ. Reduction in DNA damage in brain and peripheral blood lymphocytes of elderly dogs after treatment with dehydroepiandrosterone (DHEA). Mutat Res 2001;480-1:153-62.
13. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184-91.
14. Morris JS, Willett WC, Stampfer M. Toenails as an indicator of dietary selenium. Biol Trace Element Res 1983;5:529-37.
15. Hunter DJ, Morris JS, Chute CG, et al. Predictors of selenium concentration in human toenails. Am J Epidemiol 1990;132:114-22.
16. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1998;44:837-45.
17. Kleinsasser NH, Wallner BC, Kastenbauer ER, Muenzenrieder RK, Harreus UA. Comparing the genotoxic sensitivities of human peripheral blood lymphocytes and mucosa cells of the upper aerodigestive tract using the Comet assay. Mutat Res 2000;467:21-30.
18. Pool-Zobel BL, Dornacher I, Lambertz R, Knoll M, Seitz HK. Genetic damage and repair in human rectal cells for biomonitoring: sex differences, effects of alcohol exposure, and susceptibilities in comparison to peripheral blood lymphocytes. Mutat Res 2004;551:127-34.
19. Smith TR, Miller MS, Lohman KK, Case LD, Hu JJ. DNA damage and breast cancer risk. Carcinogenesis 2003;24:883-9.
20. Rajeswari N, Ahuja YR, Malini U, et al. Risk assessment in first degree female relatives of breast cancer patients using the alkaline Comet assay. Carcinogenesis 2000;21:557-61.
21. Blasiak J, Arabski M, Krupa R, et al. Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer. Mutat Res 2004;554:139-48. 27.
22. Colleu-Durel S, Guitton N, Nourgalieva K, et al. Alkaline single-cell gel electrophoresis (Comet assay): a simple technique to show genomic instability in sporadic breast cancer. Eur J Cancer 2004;40:445-51.
23. Shao L, Lin J, Huang M, Ajani JA, Wu X. Predictors of esophageal cancer risk: assessment of susceptibility to DNA damage using Comet assay. Genes Chromosomes Cancer 2005;44:415-22.
24. Sigurdson AJ, Hauptmann M, Alexander BH, et al. DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individuals. Mutat Res 2005;586:173-88.
25. Schabath MB, Spitz MR, Grossman HB, et al. Genetic instability in bladder cancer assessed by the Comet assay. J Natl Cancer Inst 2003;95:540-7.
26. Jaloszynski P, Kujawski M, Czub-Swierczek M, Markowska J, Szyfter K. Bleomycin-induced DNA damage and its removal in lymphocytes of breast cancer patients studied by Comet assay. Mutat Res 1997;385:223-33.
27. Kleinsasser NH, Wagner C, Wallner BC, Harreus UA, Kastenbauer ER. Mutagen sensitivity of nasopharyngeal cancer patients. Mutat Res 2001;491:151-61.
28. Rajaee-Behbahani N, Schmezer P, Risch A, et al. Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer. Int J Cancer 2001;95:86-91.
29. Bendesky A, Michel A, Sordo M, et al. DNA damage, oxidative mutagen sensitivity, and repair of oxidative DNA damage in non-melanoma skin cancer patients. Environ Mol Mutagen 2006;47:509-17.
30. Li H, Stampfer MJ, Giovannucci EL, et al. A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst 2004;96:696-703.
31. Nomura AMY, Lee J, Stemmermann GN, Combs GF. Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2000;9:883-7.
32. Brooks JD, Metter EJ, Chan DW, et al. Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 2001;166:2034-8.
33. Hu JJ, Hall MC, Grossman L, et al. Deficient nucleotide excision repair capacity enhances human prostate cancer risk. Cancer Res 2004;64:1197-201.
34. Cloos J, Nieuwenhuis EJ, Boomsma DI, et al. Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes. J Natl Cancer Inst 1999;91:1125-30.
35. Kennedy DO, Agrawal M, Shen J, et al. DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer. J Natl Cancer Inst 2005;97:127-32.
36. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000;92:874-97.
37. Trzeciak AR, Nyaga SG, Jaruga P, Lohani A, Dizdaroglu M, Evans MK. Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145. Carcinogenesis 2004;25:1359-70.
38. Kassie F, Parzefall W, Knasmuller S. Single cell gel electrophoresis assay: a new technique for human biomonitoring studies. Mutat Res 2000;463:13-31.
39. Moller P, Knudsen LE, Loft S, Wallin H. The comet assay as a rapid test in biomonitoring occupational exposure to DNA-damaging agents and effect of confounding factors. Cancer Epidemiol Biomarkers Prev 2000;9:1005-15.
40. Riso P, Pinder A, Santangelo A, Porrini M. Does tomato consumption effectively increase the resistance of lymphocyte DNA to oxidative damage? Am J Clin Nutr 1999;69:712-8.
41. Gedik CM, Grant G, Morrice PC, Wood SG, Collins AR. Effects of age and dietary restriction on oxidative DNA damage, antioxidant protection and DNA repair in rats. Eur J Nutr 2005;44:263-72.
42. Duthie SJ, Collins AR. The influence of cell growth, detoxifying enzymes and DNA repair on hydrogen per oxide-mediated DNA damage (measured using the comet assay) in human cells. Free Radic Biol Med 1997;22:717-24.
43. Tice RR, Andrews PW, Hirai O, Singh NP. The single cell gel (SCG) assay: an electrophoretic technique for the detection of DNA damage in individual cells. Adv Exp Med Biol 1991;283:157-64.